Teresa A. Heitsenrether, a newly appointed Director at CVS Health Corp, filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 18, 2026, disclosing no securities beneficially owned at the time of filing.

Key Highlights

  • Reporting Person: Teresa A. Heitsenrether is identified as a Director of CVS Health Corp (NYSE:CVS).
  • No Securities Held: The filing states explicitly, "No securities are beneficially owned."
  • Event Date: The date of event requiring the statement is listed as November 18, 2026.
  • Filing Type: This is an initial statement of beneficial ownership, covering both non-derivative and derivative securities, both of which show no holdings.
  • Filing Basis: The form was filed pursuant to Section 16(a) of the Securities Exchange Act of 1934.

CVS Health Director Heitsenrether Reports Zero Holdings on Initial Filing

According to the filing, Teresa A. Heitsenrether submitted a Form 3 Initial Statement of Beneficial Ownership in connection with her role as a Director of CVS Health Corp, listed on the exchange under the ticker CVS. The event date requiring the statement is recorded as November 18, 2026, and the form was filed on the same date.

The filing covers two tables: Table I for non-derivative securities and Table II for derivative securities, including puts, calls, warrants, options, and convertible securities. According to the filing, neither table contains any entries. The explanation of responses section states: "No securities are beneficially owned." This indicates that at the time of the triggering event, Heitsenrether held no direct or indirect beneficial ownership in any class of CVS Health securities.

The form was filed by one reporting person, as indicated by the checked box for "Form filed by One Reporting Person." Heitsenrether's address is listed as One CVS Drive, Woonsocket, Rhode Island 02895. The filing was signed by Teresa A. Heitsenrether and dated November 18, 2026.

What Was Disclosed

Teresa A. Heitsenrether, a Director at CVS Health Corp, filed an initial beneficial ownership statement dated November 18, 2026, reporting no holdings in any non-derivative or derivative securities of the company at the time of the triggering event.